دورية أكاديمية

Targeted delivery of albumin nanoparticles for breast cancer: A review.

التفاصيل البيبلوغرافية
العنوان: Targeted delivery of albumin nanoparticles for breast cancer: A review.
المؤلفون: Kunde SS; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, Maharashtra 400056, India., Wairkar S; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, Maharashtra 400056, India. Electronic address: sarika.wairkar@nmims.edu.
المصدر: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2022 May; Vol. 213, pp. 112422. Date of Electronic Publication: 2022 Feb 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4367 (Electronic) Linking ISSN: 09277765 NLM ISO Abbreviation: Colloids Surf B Biointerfaces Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam ; New York : Elsevier, c1993-
مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Nanoparticles*, Albumins ; Drug Carriers/therapeutic use ; Drug Delivery Systems ; Female ; Humans
مستخلص: Breast cancer has been identified as one of the most common cancers diagnosed in women. Various nanotechnology platforms offering unique features are considered in breast cancer treatment. Albumin is a versatile biodegradable, biocompatible, non-toxic and non-immunogenic protein nanocarrier. These characteristics attracted strong attention to fabricate albumin nanoparticles to deliver chemotherapeutic agents without major adverse effects. Albumin nanoparticles can undergo surface modifications using different ligands promoting tumor-targeted drug delivery. Moreover, multifunctional albumin nanoparticle is an upcoming strategy to attain efficient cancer therapy. This review gives an account of the potential albumin nanoparticles developed for chemotherapeutic drug delivery and its targeted approach for breast cancer. It also covers different multifunctional therapies available using albumin nanoparticles as breast cancer theranostics.
(Copyright © 2022 Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: Albumin nanoparticles; Bovine serum albumin; Breast cancer; Human serum albumin; Targeted delivery
المشرفين على المادة: 0 (Albumins)
0 (Drug Carriers)
تواريخ الأحداث: Date Created: 20220301 Date Completed: 20220419 Latest Revision: 20220419
رمز التحديث: 20240628
DOI: 10.1016/j.colsurfb.2022.112422
PMID: 35231688
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-4367
DOI:10.1016/j.colsurfb.2022.112422